Finding a rational approach to ESA therapy--for payers and patients
Affiliations
- PMID: 17918481
Item in Clipboard
Finding a rational approach to ESA therapy--for payers and patients
Nephrol News Issues.
2007 Sep.
No abstract available
Similar articles
-
ESA payment changes: chasing a moving target.Nephrol News Issues. 2008 Jan;22(1):36-7. Nephrol News Issues. 2008. PMID: 18271437 No abstract available.
-
Erythropoietin claims monitoring policy: implications of the October 2006 update continuing.Nephrol Nurs J. 2006 Nov-Dec;33(6):660-3; quiz 664-5. Nephrol Nurs J. 2006. PMID: 17219727
-
Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?ASAIO J. 1993 Jan-Mar;39(1):11-8. ASAIO J. 1993. PMID: 8439674 Review. No abstract available.
-
Erythropoietin claims monitoring policy: implications for clinical practice.Nephrol Nurs J. 2006 Mar-Apr;33(2):209-13, 222; quiz 214-5. Nephrol Nurs J. 2006. PMID: 16613415 Review.
-
Rebates for anti-anemia drugs draw response from FDA, CMS.Manag Care. 2007 Jun;16(6):17-8. Manag Care. 2007. PMID: 17682732 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical